Question 1

What are peptides?

Accepted Answer

Peptides are short chains of amino acids. The body makes many of them, including insulin, oxytocin and the gut hormone GLP-1, and uses them as signals between cells. US regulation draws a line by size: since 2020 FDA treats a chain of more than 40 amino acids as a protein. Therapeutic peptides are made in a lab to copy or modify a natural signal.

Question 2

What is the difference between a peptide and a protein?

Accepted Answer

Size, above all. FDA defines a protein as a chain of more than 40 amino acids with a specific sequence, and regulates proteins as biological products. By that rule insulin, at 51 amino acids, is a protein, while semaglutide and tirzepatide are peptides regulated as drugs. Outside regulation the boundary is less sharp, and scientists use both words for chains near the line.

Question 3

Are peptides the same as steroids?

Accepted Answer

No. Steroids are built on a cholesterol-derived ring structure; peptides are chains of amino acids. But peptides can act on hormones powerfully: GnRH analogues such as leuprolide lower testosterone, and growth hormone releasers raise growth hormone. That is why several peptides are on WADA's Prohibited List.

Question 4

Are peptides natural?

Accepted Answer

The body makes hundreds of peptides, and some medicines are close copies of them. Most therapeutic and research peptides, though, are synthetic and modified: semaglutide, for example, differs from human GLP-1 so that it lasts about a week instead of minutes. Natural origin says nothing about whether a product is safe or what is in a vial.

Question 5

How do peptides work in the body?

Accepted Answer

A peptide binds to a receptor on a cell, like a key in a lock, and triggers a signal inside the cell. Which receptor it binds decides what it does. For approved peptide medicines, trials have measured what that means in people; for most research peptides, the effects claimed online come from cell and animal studies and have not been tested in people.

Question 6

What are the main categories of peptides?

Accepted Answer

People usually group them by goal: weight and metabolism, tissue repair, growth hormone, cognition, longevity and immune support. The groups differ in evidence. Weight management has approved medicines with large trials; growth hormone has two approved treatments for specific diagnoses; the other groups have no FDA-approved peptide. Our encyclopedia gives each compound's status and evidence level.

Question 7

What is a peptide bond?

Accepted Answer

The chemical bond that links one amino acid to the next. It forms when the carboxyl group of one amino acid joins the amino group of another and releases a molecule of water. The order of amino acids along those bonds, and the shape the chain folds into, decide what the peptide binds to.

Question 8

What does 'lyophilized' mean?

Accepted Answer

Freeze-dried. Many peptides are supplied as a lyophilized powder because they keep better dry, and the powder is dissolved (reconstituted) in a liquid before use. Approved products say on their labels which liquid to use and how long the solution keeps; research-use products have no such label.

Question 9

What is bacteriostatic water?

Accepted Answer

Sterile water with 0.9% benzyl alcohol, a preservative that inhibits bacterial growth, so one vial can be punctured more than once. A multiple-dose vial is generally discarded 28 days after it is first punctured. The preservative limits bacteria; it does not keep a dissolved peptide potent.

Question 10

How do I calculate my peptide dose?

Accepted Answer

The arithmetic is simple: divide the amount of peptide in the vial by the volume of liquid added to get a concentration, then divide the dose by the concentration to get the volume to draw. Our calculator does this and shows it on a syringe. What it cannot do is tell you the dose itself: for approved medicines that comes from the label and a prescriber, and for research peptides no dose has been tested.

Question 11

What does 'mcg' mean vs 'mg'?

Accepted Answer

Micrograms and milligrams. 1 mg = 1,000 mcg, so mixing them up is a thousand-fold error. Vials are usually labelled in milligrams and doses are often written in micrograms, which is exactly where mistakes happen. Check the unit on every number before converting.

Question 12

What are 'units' on an insulin syringe?

Accepted Answer

Markings for volume, not for drug. On a U-100 insulin syringe, 100 units = 1 mL, so 10 units = 0.1 mL and 1 unit = 0.01 mL, whatever is dissolved in it. FDA has received reports of people taking several times their intended dose of a compounded GLP-1 medicine because units, millilitres and milligrams were confused.

Question 13

How many doses can I get from one vial?

Accepted Answer

Divide the amount in the vial by the dose: a 10 mg vial at 0.5 mg per dose holds 20 doses by content. Then check time: a multiple-dose vial made up with bacteriostatic water is generally discarded 28 days after first puncture, so a vial that would last longer than that wastes the remainder. Our calculators account for both.

Question 14

What is a 'loading phase' and do I need one?

Accepted Answer

A loading phase, a period of higher doses at the start, comes from community protocols. The approved peptide medicines do the opposite: Wegovy starts at 0.25 mg a week and rises every 4 weeks, and Zepbound starts at 2.5 mg, because starting low reduces gastrointestinal side effects. No trial has tested the loading schedules quoted online for research peptides.

Question 15

Can I take peptides every day?

Accepted Answer

It depends on the medicine's label. Semaglutide and tirzepatide injections are weekly; liraglutide and tesamorelin are daily; Wegovy tablets are daily. For research peptides, the frequencies traded online are conventions, not schedules tested in people. Each encyclopedia entry shows which doses, if any, were studied.

Question 16

What time of day should I take peptides?

Accepted Answer

For approved medicines, the label says. Wegovy and Zepbound injections can be taken at any time of day, with or without meals; Wegovy tablets, Icotyde and Lipfendra must be taken on an empty stomach in the morning, 30 minutes before food. Timing advice for research peptides, such as bedtime dosing for growth hormone releasers, is community practice, not a tested result.

Question 17

Do I need to cycle peptides?

Accepted Answer

The cycles quoted online, such as weeks on and weeks off, are community conventions; none has been tested. For approved GLP-1 medicines the trials point the other way: when people stopped semaglutide or tirzepatide, most of the lost weight returned within a year. Stopping or pausing a prescribed medicine is a decision for the prescriber.

Question 18

What happens if I take too much of a peptide?

Accepted Answer

For approved medicines, the label describes overdose; with GLP-1 medicines, severe nausea and vomiting are typical, and FDA has received reports of hospitalisations after compounded semaglutide doses several times too high. If you think you have taken too much, contact a poison control center or emergency care. For research peptides, nobody knows what an overdose does.

Question 19

What does 'stacking' peptides mean?

Accepted Answer

Taking several compounds at once, usually because each is claimed to work a different way. No combination of research peptides has been tested in a human trial, so a stack multiplies what is unknown. The one peptide combination tested at scale, cagrilintide with semaglutide (CagriSema), was developed and trialled as a single product and is still awaiting an FDA decision.

Question 20

What are the best peptide stacks for beginners?

Accepted Answer

There is no evidence-based stack for beginners or anyone else, because no stack of research peptides has been tested in people. Where approved medicines exist for a goal, such as weight management, they were tested alone and are prescribed alone. Our beginner's guide shows, goal by goal, what is approved and what is only discussed.

Question 21

Can I mix two peptides in the same syringe?

Accepted Answer

Only when a label or a pharmacist says the two are compatible. The labels of approved peptide medicines give no mixing instructions, and pens are not designed to be combined. For research peptides there are no compatibility data at all, so a mixture could change what is delivered in ways no one has measured.

Question 22

How many peptides can I take at once?

Accepted Answer

No number is safe by default. Each added compound adds combinations no one has tested, more injections and more to track, and makes it impossible to tell which one caused a side effect. If you take any prescribed medicine, tell the prescriber about everything else you take.

Question 23

Which peptides should NOT be combined?

Accepted Answer

The clearest rules are on labels. Zepbound's says it is not recommended with other tirzepatide products or with any GLP-1 receptor agonist, which rules out combining semaglutide and tirzepatide. GLP-1 medicines raise the risk of low blood sugar with insulin or sulfonylureas. Our interaction checker marks which ratings come from labels and which are untested.

Question 24

How much bacteriostatic water should I add to my peptide vial?

Accepted Answer

For an approved product, the amount its instructions give. Otherwise the volume changes only the concentration: more liquid means each dose is a larger volume, which is easier to measure on a syringe but uses up the vial's 28-day window no faster or slower. Our calculator shows the concentration and syringe marking for any volume.

Question 25

Can I use regular water instead of bacteriostatic water?

Accepted Answer

No. Tap, bottled or distilled water is not sterile. Sterile water without a preservative is for single use only, because nothing stops bacteria growing after the first puncture. Bacteriostatic water contains benzyl alcohol for multiple-dose use. Approved products specify their own diluent.

Question 26

Why can't I shake the peptide vial?

Accepted Answer

Labels for reconstituted peptide medicines tell patients to roll or swirl gently rather than shake: EGRIFTA SV's instructions are to roll the vial between the hands. Vigorous shaking can foam the solution and damage protein and peptide drugs. Let bubbles settle before drawing a dose.

Question 27

What does it mean if the solution is cloudy?

Accepted Answer

Labels for approved peptide medicines say not to use a solution that is cloudy, discoloured or contains particles, because it may be degraded or contaminated. GHK-Cu is an exception in colour, not in rules: the copper makes it blue, but cloudiness or particles are still a reason not to use it.

Question 28

Can I pre-load syringes for convenience?

Accepted Answer

Labels for approved medicines give no instructions for pre-filling syringes, and doing so adds handling and contamination risk and leaves a dose sitting in a container it was not tested in. Draw each dose when you use it, with a new needle.

Question 29

Do I need to add BAC water slowly?

Accepted Answer

Yes. Instructions for reconstituted peptide medicines such as EGRIFTA SV direct the liquid in gently and the vial rolled, not shaken, so the powder dissolves without foaming. Aim the stream at the glass wall rather than the powder, and wait for it to dissolve completely.

Question 30

Where should I inject peptides?

Accepted Answer

The labels of subcutaneous peptide medicines name the abdomen, thigh and upper arm, and tell patients to rotate sites. Injecting near an injury is a community practice with no human evidence behind it. Rotating sites helps prevent lumps and skin changes from repeated injections in one spot.

Question 31

What is the difference between subcutaneous and intramuscular injection?

Accepted Answer

A subcutaneous injection goes into the fat layer under the skin, usually with a short insulin needle; an intramuscular injection goes into muscle with a longer needle. Most peptide medicines are subcutaneous. The route changes how fast a drug is absorbed, so it is not interchangeable unless the label says so.

Question 32

Does injecting peptides hurt?

Accepted Answer

Insulin needles are very fine, and most injections cause brief, mild discomfort. Pain is worse with reused needles, which dull quickly, and with cold solutions. Labels for approved medicines say to use a new needle for every injection and never to share needles or pens.

Question 33

Can I inject multiple peptides at the same time?

Accepted Answer

Not in one syringe unless a label or pharmacist says the products are compatible. If you take more than one injected medicine, inject them separately, at different sites, and make sure your prescriber knows about all of them.

Question 34

How do I avoid bruising from injections?

Accepted Answer

Use a new needle each time, inject slowly, avoid visible veins, rotate sites and press gently rather than rubbing afterwards. Occasional small bruises are common; a lump that grows, a spreading redness or pain that worsens needs medical attention.

Question 35

What is an intranasal peptide and how do I use it?

Accepted Answer

A peptide sprayed into the nose to be absorbed through its lining. Semax and Selank are approved as nasal sprays in Russia, not in the US, and how much of either reaches the brain in people is not well established. For any nasal medicine, follow its own instructions.

Question 36

How long does reconstituted peptide last?

Accepted Answer

A multiple-dose vial made up with bacteriostatic water is generally discarded 28 days after first puncture; that is a limit on sterility, not a promise of potency. Approved products state their own storage times. For most research peptides no stability data exist, so no one knows how long they stay potent in solution.

Question 37

Can I freeze reconstituted peptides?

Accepted Answer

The labels of approved peptide medicines say not to freeze them and not to use them if they have been frozen: Wegovy's and Zepbound's both say so. Freezing can damage the solution and the container. For research products there are no data either way.

Question 38

How should I store peptide powder before reconstitution?

Accepted Answer

Follow the product's label. Approved peptide medicines state their storage conditions, usually refrigeration and protection from light. Research-use products have no tested storage conditions, and a product that arrives warm after shipping may already have degraded; no test at home can tell.

Question 39

Can I travel with peptides?

Accepted Answer

Keep medicines in your carry-on, in their original packaging with the prescription label, and use an insulated case if they need to stay cold. TSA screening permits injectable medications and syringes in carry-on bags. Rules for bringing medicines into another country vary, so check before you go.

Question 40

Does light damage peptides?

Accepted Answer

It can. Zepbound's label says to protect the pens from heat and light and keep them in the original carton. Keep any peptide product in its packaging, away from direct sunlight.

Question 41

Are peptides safe?

Accepted Answer

It depends on which one. Approved peptide medicines have labels based on trials in thousands of people, listing their risks and how to manage them. Most research peptides have little or no human safety data: BPC-157, for example, has been studied mostly in animals. Products sold for research have also been found overfilled and contaminated.

Question 42

What are common side effects of peptides?

Accepted Answer

For approved medicines, the labels give rates: nausea affected 44% of people on Wegovy against 16% on placebo, and 25% to 29% on Zepbound against 8%; EGRIFTA SV's injection-site reactions were 25% against 14%. MK-677, a growth hormone releaser that is not a peptide, raised blood sugar in a trial, and another trial was stopped because of heart failure. For most research peptides, side effects are simply unknown.

Question 43

Can peptides cause cancer?

Accepted Answer

For approved GLP-1 medicines, the labels carry a boxed warning about thyroid C-cell tumors seen in rodents and say it is unknown whether they occur in humans; a large Scandinavian cohort found no substantially increased risk of thyroid cancer. For research peptides such as BPC-157, whose animal studies report effects on blood vessel growth, long-term cancer risk in people has never been studied.

Question 44

Can I take peptides with prescription medications?

Accepted Answer

Some combinations matter. GLP-1 medicines slow stomach emptying: oral semaglutide raised levothyroxine exposure by a third, and Mounjaro's label tells users of oral contraceptives to add a barrier method for 4 weeks after starting and after each dose increase. Tell your prescriber and pharmacist about everything you take.

Question 45

Do I need bloodwork before starting peptides?

Accepted Answer

For a prescribed medicine, your clinician decides what to test, based on the drug and your health. There is no standard panel that makes an untested compound safe to take, and a normal blood test cannot tell you what is in a vial.

Question 46

Can women use peptides?

Accepted Answer

Some approved peptide medicines are used by women and one is for women only: Vyleesi is approved for hypoactive sexual desire disorder in premenopausal women. Pregnancy needs planning: Wegovy's label says to stop it when pregnancy is recognized and at least 2 months before a planned pregnancy, because semaglutide lasts so long in the body. Research peptides have no pregnancy data.

Question 47

Are peptides addictive?

Accepted Answer

Approved peptide medicines such as semaglutide and tirzepatide are not known to cause dependence, but stopping them has consequences: in the withdrawal trials, most of the weight lost came back within a year. For research peptides, there are no data on dependence or withdrawal.

Question 48

Are peptides legal in the United States?

Accepted Answer

It depends on the peptide and how it is supplied. Approved peptide medicines are legal with a prescription. Compounding is lawful only within sections 503A and 503B: in April 2026 FDA removed twelve peptides from its Category 2 list after their nominations were withdrawn, which did not make them compoundable, and its advisory committee voted on several peptides in July; FDA had not acted as of September 30, 2026. Products sold 'for research use only' are not approved for people.

Question 49

What is the FDA Category 2 list?

Accepted Answer

Part of FDA's interim list of bulk drug substances nominated for compounding under section 503A: Category 2 holds substances that raise significant safety risks, which pharmacies may not compound under the interim policy. In April 2026 FDA removed twelve peptides from it after their nominations were withdrawn; a substance off the list is not thereby allowed. The regulatory tracker gives each peptide's current position.

Question 50

What is a 503A vs 503B pharmacy?

Accepted Answer

A 503A pharmacy compounds for individual patients on prescriptions, from bulk substances that meet the section's conditions. A 503B outsourcing facility is registered with FDA, can make medicines without individual prescriptions, and must follow current good manufacturing practice. Neither may compound a substance that meets none of its section's conditions.

Question 51

Can I buy peptides without a prescription?

Accepted Answer

Approved peptide medicines require one. Products sold without a prescription as 'research chemicals' are not approved for human use, and in August 2026 FDA told five online sellers that such labels did not outweigh websites showing the products were meant for people. Testing of products bought online has found overfilled and contaminated vials.

Question 52

Are peptides banned in sports?

Accepted Answer

Many are. WADA prohibits growth hormone and its releasing factors at all times, and from January 1, 2027 its catch-all ban on unapproved substances names peptides explicitly, with BPC-157 as a named example. GLP-1 medicines such as semaglutide are not prohibited; WADA monitors them. Athletes should check the list in force and ask their anti-doping organisation.

Question 53

Are peptides legal in Europe, UK, Canada, and Australia?

Accepted Answer

Each country regulates medicines itself: the EMA and national agencies in the EU, the MHRA in the UK, Health Canada and the TGA in Australia. Approved peptide medicines are prescription-only in all of them, and research-chemical products are not approved medicines anywhere. Check the national regulator for a specific compound.

Question 54

Do I need to change my diet while using peptides?

Accepted Answer

The weight-management labels approve GLP-1 medicines as an adjunct to a reduced-calorie diet and increased physical activity. Some oral peptides need an empty stomach: Wegovy tablets, Icotyde and Lipfendra all say 30 minutes before food. Dietary rules for research peptides, such as fasting before growth hormone releasers, are community practice.

Question 55

Can I exercise while using peptides?

Accepted Answer

Yes, and for the approved weight-management medicines, increased physical activity is part of the labelled use. Claims that research peptides enhance training or recovery come mostly from animal studies. If you are recovering from an injury, follow your clinician's or physiotherapist's plan.

Question 56

Does alcohol affect peptides?

Accepted Answer

With GLP-1 medicines, alcohol adds to the risk of low blood sugar for people who also take insulin or a sulfonylurea, and it can add to stomach upset. Ask your prescriber what is sensible for you. For research peptides, there are no data.

Question 57

Can I use peptides while fasting?

Accepted Answer

Injected semaglutide and tirzepatide can be taken with or without meals, according to their labels. Oral peptides such as Wegovy tablets must be taken on an empty stomach. If you use insulin or a sulfonylurea with a GLP-1 medicine, fasting raises the risk of low blood sugar; talk to your prescriber first.

Question 58

How long until I see results from peptides?

Accepted Answer

For approved medicines, the trials measured it: semaglutide's and tirzepatide's weight-loss trials ran 68 to 72 weeks, with weight falling steadily through dose escalation. For research peptides, no trial has measured a timeline in people, so any promise of results within weeks is anecdote.

Question 59

Will I lose my results if I stop taking peptides?

Accepted Answer

For GLP-1 medicines, the withdrawal trials say yes, mostly: after stopping semaglutide or tirzepatide, most of the lost weight returned within a year. For research peptides there are no human data on what lasts after stopping.

Question 60

What is BPC-157 and what is it used for?

Accepted Answer

A synthetic 15-amino-acid peptide based on a protein in gastric juice, sold online for injuries and gut problems. It is not approved anywhere. Its evidence comes mostly from animal studies; the human data are small pilot studies. WADA names it in its ban on unapproved substances. The encyclopedia entry lists every study.

Question 61

What is the difference between semaglutide and tirzepatide?

Accepted Answer

Semaglutide (Ozempic, Wegovy) activates the GLP-1 receptor; tirzepatide (Mounjaro, Zepbound) activates GLP-1 and GIP receptors. In SURMOUNT-5, the head-to-head trial in adults with obesity, tirzepatide produced 20.2% weight loss at 72 weeks against 13.7% for semaglutide. Both are approved, prescription-only weekly injections.

Question 62

What is GHK-Cu?

Accepted Answer

A copper-binding tripeptide found in human plasma and sold widely in skin care. The evidence for its other uses is mostly cell and animal work, with few trials in people, and it is not approved as a medicine. Cosmetic products containing it are regulated as cosmetics, not drugs.

Question 63

What is the CJC-1295/Ipamorelin stack?

Accepted Answer

A combination sold online of two growth hormone releasers: CJC-1295 without DAC (modified GRF 1-29) and ipamorelin. No human trial has tested the combination. Neither is approved; ipamorelin reached a phase 2 trial after surgery that found no benefit. Both are prohibited in sport.

Question 64

What are MOTS-c and SS-31?

Accepted Answer

Two mitochondria-related peptides with very different standing. SS-31, as elamipretide (Forzinity), is FDA-approved for Barth syndrome, a rare genetic disease. MOTS-c is a research peptide studied mainly in animals for metabolism and exercise capacity, and WADA prohibits it. Neither is approved for longevity.

Frequently Asked Questions

Peptide basics